Review decisions
Showing 910 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00845
Product Type: Drug
Control Number: 243652
DIN(s): 02519283, 02519291
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-09-09
Decision / Authorization Date: 2021-08-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00849
Product Type: Drug
Control Number: 247025
DIN(s): 02518627
Manufacturer: Incyte Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-12-04
Decision / Authorization Date: 2021-08-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00271
Issued / Original Publication Date: 2021-08-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00607
Product Type: Drug
Control Number: 255700
DIN(s): 02528320, 02528339
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-13
Issued / Original Publication Date: 2022-10-06
Decision / Authorization Date: 2022-06-22
Updated Date: 2025-03-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1723561016707
Product Type: Drug
Control Number: 255697
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-08-12
Decision / Authorization Date: 2024-06-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00917
Product Type: Drug
Control Number: 241318
DIN(s): 02519011, 02519038
Manufacturer: Aralez Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-07-07
Decision / Authorization Date: 2021-08-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00840
Product Type: Drug
Control Number: 247678
DIN(s): 02518244
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00850
Product Type: Drug
Control Number: 249112
Manufacturer: Kyowa Kirin, Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-02-05
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00964
Product Type: Drug
Control Number: 248367
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2021-01-15
Decision / Authorization Date: 2021-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00582
Product Type: Drug
Control Number: 254598
Manufacturer: Medicago Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-08-09
Issued / Original Publication Date: 2022-04-11
Decision / Authorization Date: 2022-02-24
Updated Date: 2023-05-26